Geron Corporation
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Geron Corporation's yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Self-Funding Ratio: Over the last 3 years operating cash was negative while the company kept spending on investment (capex). Lower than 93% of Healthcare companies in United States.
- Debt Due Cover Ratio: Operating cash was negative last year, while some debt falls due within a year. Lower than 85% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-319.0×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 93% of Healthcare companies in United States.
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
2/3 · 2/3Sales grew in 2 of the last 3 years; profit grew in 2 of 3.
Steadier than 69% of Healthcare companies in United States.
Growth Efficiency Ratio
$32Sales grew 30,753% in 3 years; of every extra $100 of sales, $32 became extra profit.
Higher than 59% of Healthcare companies in United States.
Asset Productivity Ratio
+30753% / +199%In 3 years sales changed by +30753% while total assets changed by +199%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
-111.0×Operating cash was negative last year, while some debt falls due within a year.
Lower than 85% of Healthcare companies in United States.
Cash Cushion Ratio
+32%Cash, after subtracting all debt, equals 32% of its market value (net cash).
Higher than 70% of Healthcare companies in United States.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Geron Corporation made a loss over the last year. Geron Corporation owes $0.58 for every $1 it owns. Geron Corporation made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossGeron Corporation made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
3.32The share price is 3.32 times Geron Corporation's book value per share, higher than 59% of Healthcare companies in United States.
Market cap
$726 MThe total market value of all of Geron Corporation's shares at today's price (share price × number of shares), larger than 61% of Healthcare companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
$219 MWhat Geron Corporation would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$0.34Net worth divided by the number of shares. The share price of $1.13 is 3.3 times this, which is the P/B above.
Return on equity (ROE)
-28.3%Geron Corporation lost 28.3% of its shareholders' money over the last year, higher than 61% of Healthcare companies in United States.
Owes vs Owns
0.58×Geron Corporation owes $0.58 for every $1 it owns (moderate), higher than 62% of Healthcare companies in United States.
Dividend yield
NoneGeron Corporation does not currently pay a dividend.
Revenue growth
+139%Revenue rose 139% in the year to Dec 2025, and grew 576% a year on average over 3 years.
Profit growth
LossGeron Corporation made a loss in each of the last two years.
Profit margin
-45.4%Geron Corporation lost $45 for every $100 of revenue.
Interest cover
Not coveredGeron Corporation's operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net cashGeron Corporation held $236 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Geron Corporation: $726 M ÷ $219 M (30 Jun 2026) = 3.3.
What is Geron Corporation's return on equity?
Geron Corporation lost 28.3% of its shareholders' money over the last year, higher than 61% of Healthcare companies in United States.
How much does Geron Corporation owe compared with what it owns?
Geron Corporation owes $0.58 for every $1 it owns (moderate), higher than 62% of Healthcare companies in United States.
Does Geron Corporation pay a dividend?
No. Geron Corporation does not currently pay a dividend.
Is Geron Corporation's revenue growing?
Revenue rose 139% in the year to Dec 2025, and grew 576% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.